Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Placenta. 2016 Oct 10;48:34–37. doi: 10.1016/j.placenta.2016.10.004

The function of miR-519d in cell migration, invasion, and proliferation suggests a role in early placentation

Lan Xie 1, Yoel Sadovsky 2
PMCID: PMC5130096  NIHMSID: NIHMS823450  PMID: 27871470

Abstract

The processes of proliferation, migration, and invasion of extravillous trophoblasts are critical for placental implantation and early development, and directly influence pregnancy outcome. Dysregulation of these processes has been associated with placental dysfunction, implicated in clinical conditions such as preeclampsia and placental accreta. Among diverse microRNA (miRNA) species that are expressed in placental trophoblasts, members of the chromosome 19 miRNA cluster (C19MC) stand out in their nearly exclusive expression in the placenta. Recent research on the function of C19MC miRNAs in normal cell physiology and during tumorigenesis identified one C19MC member, miR-519d, as a regulator of cell migration, invasion, and interaction with the extracellular matrix. In this review, we focus on the function of miR-519d in placental trophoblasts, where miR-519d regulates cell migration and invasion, and its aberrant expression is associated with preeclampsia. In cancer, the function of miR-519d as an oncomiR or a tumor-suppressor is dependent upon the tumor type. Further research on the biological function and regulation of miR-519d may illuminate previously unknown mechanisms that control cell migration and invasion.

Keywords: Placenta, miRNA, C19MC, miR-519d, invasion

Introduction

Early trophectoderm implantation within the uterine wall, followed by migration and invasion of trophoblastic columns within the decidua and inner myometrial layer, are central for fetal development [1]. Shallow or excessive implantation has been associated with important diseases of pregnancy, such as preeclampsia and placental adhesion disorders [2]. Interestingly, trophoblast invasion that occurs during normal development resembles malignant cell invasion during tumorigenesis. This similarity suggests that analogous processes might regulate normal trophoblast invasion and tumor formation. In this review we focus on miR-519d, a member of the chromosome 19 miRNA cluster (C19MC). MiR-519d has been implicated in regulation of trophoblast migration and tumor formation, shedding light on previously unknown functions of C19MC members.

Invasion, proliferation, and migration during placental development

Placental implantation is a central event during pregnancy. Whereas trophoblasts in the chorionic villi play a critical role in the regulation of gas and nutrient exchange and elimination of fetal waste, the extravillous trophoblast (EVT) invades into the maternal decidua and inner myometrium to form the implantation and early maternal-fetal exchange site [3,4]. These two trophoblast types can produce paracrine and endocrine signals and immunologically protect the pregnancy [3]. Among EVT subtypes, interstitial EVTs migrate into the decidua and the inner third of the myometrium and anchor the placenta to the maternal tissues, while endovascular EVTs penetrate and remodel the maternal spiral arteries [1]. In this process, also known as pseudovasculogenesis, the uterine spiral arteries are transformed into low-resistance, high-flow vessels, enabling sufficient blood supply to the placental bed. The failure of this physiologic conversion of uterine spiral arteries may lead to placental hypoperfusion, tissue injury, and trophoblast hypoxia and their consequences including fetal death, growth restriction, and preeclampsia [2,5].

The process of EVT invasion is tightly orchestrated, leading to the formation of placental cell columns, architecture remodeling, and proper vascular support [6,7]. To date, various mechanisms have been proposed to govern the proliferation, migration, invasion, and differentiation of EVTs. The main regulators of this process include cell adhesion molecules, integrins, growth factor receptors and their ligands, such as EGF, TGFβ and IGF2, enzymes that govern extracellular matrix degradation, angiogenesis, and immune response [1].

Placental health and C19MC miRNAs

Diverse miRNA species participate in modulation of gene expression in many physiological and pathological processes, including embryogenesis and placental development and function [8]. Several miRNAs were shown to regulate trophoblast migration and invasion, either by facilitating or by inhibiting these processes. These miRNA are summarized in Table 1. One of the most fascinating families of trophoblast-related miRNAs is the C19MC. C19MC is the largest human miRNA gene cluster, spanning an approximately 100 kb region. It consists of 46 miRNA genes encoding a total of 58 mature miRNAs [9]. This cluster is present only in the primate and human genome and expresses miRNAs primarily in placenta [10] and, at a lower level, in embryonic stem cells and in certain tumors [1114]. The functions of C19MC miRNAs in cancer are divergent, exhibiting either oncogenic or tumor-suppressive functions, depending on the tumor type [13]. C19MC miRNAs are among the most abundant miRNAs in the human placenta and in the plasma of pregnant women [15,16]. Their levels gradually increase in the maternal circulation as pregnancy progresses and rapidly decline after delivery. While their function is not entirely clear, we recently found that C19MC miRNAs are packaged within trophoblastic exosomes and confer viral resistance to non-trophoblastic cells by the induction of autophagy [1720].

Table 1.

MiRNAs implicated in regulation of trophoblastic processes relevant to invasion

Name Chromosomal location Cells or tissue tested Biological process Putative targets References
microRNA-137 1p21.3 Human placental tissue and trophoblast cells Proliferation and migration ERRα [42]
miR-15b 3q25.33 Placental tissue, HTR-8/SvNeo Invasion, angiogenesis AGO2 [43]
miR-141 12p13.31 Placental tissue, JEG-3 and HTR-8/SVneo Invasion, intercellular communication - [44]
miR-193b-3p 16p13.12 Placental tissue, HTR-8/SVneo Migration and invasion TGF-β2 [45]
miR-661 8q24.3 Primary human endomerial epithelial cells, HTR-8/SVneo Adhesion EBPH2, PVRL1, MTA1, MTA2 [46]
miR-34a 1p36.22 Placental tissue, JEG-3, JAR Invasion MYC, PAI-1 Notch1, Jagged1 [4749]
miR-204 9q21.12 BeWo and JEG3 Invasion MMP9 [50]
miR-18a 13q31.3 JEG3 Invasion, apoptosis ESRα [51]
miR-135b 1q32.1 HTR-8/SVneo Invasion CXCL12 [52]
miR-125b-1-3p 11q24.1 Placental tissue, HTR-8/SVneo Invasion S1PR1 [53]
miR-20a 13q31.3 Placental tissue, JEG-3 Proliferation, migration and invasion FOXA1 [54]
miR-155 21q21.3 HTR-8/SVneo Proliferation and migration eNOS, cyclinD1 [55,56]
miR-101 1p31.3 HTR-8/SVneo Apoptosis ERp44 [57]
miR-376c 14q32.31 HTR-8/SVneo Proliferation, migration, and invasion ALK5, ALK7 [58]
miR-195 17p13.1 Placental tissue, HTR-8/SVneo Invasion ActRIIA [59]
miR-29b 7q32.3 HTR-8/SVneo, BeWo and JAR Apoptosis, invasion and angiogenesis MCL1, MMP2, VEGFA, ITGB1 [60]
miR-378a-5p 5q32 Placental tissue, HTR-8/SVneo Cell growth, surviv al migration, invasion Nodal [61]
miR-519d 19q13.42 Placental tissue, HTR-8/SVneo Invasion, migration MMP2, CXCL6, NR4A2, FOXL2 [28,30]

Altered placental expression or plasma levels of C19MC miRNAs has been observed in diseases associated with placental dysfunctions such as preeclampsia [2125]. Upregulation of several C19MC miRNAs is associated with increased risk of gestational hypertension [26]. Higashijima et al. identified seven miRNA members of C19MC exhibiting a significantly lower expression level in placentas from pregnancies complicated by fetal growth restriction, although these changes were not observed in maternal plasma miRNA levels [16,23,27].

Placental miR-519d and its function in trophoblast invasion, proliferation, and migration

We recently showed that C19MC miRNAs have a differential distribution within the human placenta, with a higher expression in villous trophoblasts compared to EVTs, both in primary placenta tissues and cell lines [28]. Specifically, we found that a representative C19MC miRNA, miR-518b, is highly expressed in VT cell lines including JEG3, BeWo and Jar, but not in the EVT line HTR-8/SVneo [28]. Morales-Prieto et al also reported that the C19MC is absent in HTR-8/SVneo cells but strongly expressed in JEG-3 cells [29]. In contrast, Ding et al reported that miR-519d-3p was significantly downregulated in JEG-3 cells compared to HTR-8/SVneo cells [30]. This discrepancy may reflect a different cell line source or other experimental conditions. Importantly, upon stable transfection of C19MC miRNAs into HTR-8/SVneo cells [28], we found that these miRNAs selectively attenuate cell migration without affecting cell proliferation or apoptosis. We subsequently found that miR-519d directly silences the expression of several mRNAs that were downregulated during migration of HTR-8/SVneo cells, such as CXCL6, FOXL2, and NR4A2 [28]. In findings similar to our results, Ding et al. found that overexpression of miR-519d significantly inhibited the migration and invasion of HTR-8/SVneo cells, whereas transfection of a miR-519d inhibitor had the opposite effect. Moreover, their data suggest that MMP2 is directly silenced by miR-519d, suggesting a mechanism for reduced invasion [30]. Others found that in certain experimental conditions miR-519d enhanced cell proliferation and migration (Chaiwangyen W, Morales-Prieto DM, Markert UR, manuscript in preparation). A number of C19MC miRNAs, including miR-519d, were upregulated in the plasma of women with early-onset preeclampsia, a condition associated with shallow placental invasion [25]. Similar upregulation of miR519d in preeclampsia was found by others [24].

The expression and function of miR-519d in non-placental tissues

The published data on the function of miR-519d during tumorigenesis suggest a complex role which may be explained by the non-uniform regulation of invasion in different tumors. A summary of miR-519d roles in different tumors is listed in Table 2.

Table 2.

The role of miR-519d in tumorigenesis

Role Tumors Putative targets References
Oncogenic Hepatocellular carcinoma CDKN1A/p21, PTEN, AKT3, and TIMP2 [31,32]
Cervical cancer Smad7 [33]
Multiple myeloma - [34]
Tumor suppressive Hepatocellular carcinoma MKi67 [35]
Lung adenocarcinoma TGFβ signaling [36]
Human osteosarcoma MMP-2 and MMP-3 [37]
Ovarian cancer XIAP [38]
Breast cancer STAT3 [39]
Chondrosarcoma MMP2 [40]

Several studies suggest that miR-519d is overexpressed in some human cancers and possesses oncogenic properties. One example is hepatocellular carcinoma (HCC), where miR-519d was found to be overexpressed and to promote cell proliferation, invasion, and impaired apoptosis, acting through the targeting of CDKN1A/p21, PTEN, AKT3, and TIMP2 [31]. A follow-up study by the same group showed that miR-519d was elevated in the serum of patients with HCC and that miR-519d could be used to distinguish cirrhotic patients without HCC from cirrhotic patients with early and intermediate-advanced HCC [32]. In a study of cervical cancer, miR-519d was found to be significantly upregulated in cervical cancer samples, where it promoted the migration and invasion of HeLa and SiHa cervical cancer cells and the proliferation of cervical cancer cells through targeting Smad 7 [33]. miR-519d is also overexpressed in bone marrow mesenchymal stromal cells of multiple myeloma patients compared to bone marrow mesenchymal stromal cells of donors [34].

While the non-placental expression of miR-519d has been associated with tumorigenesis in some studies, an anti-tumor function of miR-519d has been shown by others. MiR-519d suppresses the growth of the human HCC cell line QGY-7703 through targeting MKi67, a proliferation marker protein [35]. In the lung adenocarcinoma A549 cell line, miR-519d inhibited TGFβ signaling and thus attenuated the enhancement of cell proliferation, morphology, and scattering by TGFβ [36]. Similarly, in human osteosarcoma, connective tissue growth factor (CTGF) increases matrix metalloproteinase expression and promotes tumor metastasis through downregulation of miR-519d [37]. The anti-metastatic function of miR-519d was also evident in its direct suppressive effect on MMP-2 and MMP-3 [37]. In ovarian cancer cell lines and tissues, the expression of miR-519d was downregulated, and overexpression of miR-519d in ovarian cancer cells repressed cell proliferation and potentiated cisplatin-induced cell death by targeting X-linked inhibitor of apoptosis protein (XIAP) [38]. Similarly, the levels of miR-519d are reduced in breast cancer tissues and cell lines, while overexpression of miR-519d inhibits cell proliferation and invasion and induces apoptosis in breast cancer cells, probably through targeting signal transducer and activator of transcription 3 (STAT3) [39]. Lastly, transfection of miR-519d into chondrosarcoma cells diminished resistin-induced cell migration and directly silenced the expression of MMP-2 [40]. Taken together, while available information supports a role for miR-519d in the regulation of cell invasion, migration, and proliferation, the effect of miR-519d in this context is divergent, and seems to depend on the context of specific tissues and tumors. It is thus possible that miR-519d regulates dissimilar target proteins in different tumors, or that the function of miR-519d may be influenced by the degree of cellular differentiation or by tumor-specific microenvironment factors. Similar factors may underlie the function of miR-519d during trophoblast migration and invasion. Additional detailed studies are needed in order to elucidate the context-specific expression and action of miR-519d.

It is also possible that miR-519d plays a role in other processes, as suggested by the overexpression of miR-519d in subcutaneous adipose tissue of severely obese humans, where it may suppress the expression of peroxisome proliferator-activated receptor-α and increase lipid accumulation during preadipocyte differentiation [41].

Conclusion

Implantation, placental development and function, and consequently, the outcome of pregnancy are utterly dependent upon proper EVT invasion, proliferation, and migration. Among numerous signals that regulate these processes, miRNAs regulate the expression of proteins relevant to invasion, proliferation, and migration. Although the function of C19MC miRNA in EVTs remains to be fully elucidated, data from several laboratories, including our own, suggest that the C19MC member miR-519d regulates EVT migration and, possibly, invasion. Further support for this function of miR-519d is derived from the process of tumorigenesis. While the data are not uniform, and experimental results are largely dependent upon the experimental system, ample evidence points to the role of miR-519d in regulating the expression of discrete proteins involved in cell interaction with the extracellular matrix and in migration and invasion. These data may serve to illuminate the pathogenesis of diseases associated with abnormal placentation, such as preeclampsia, placental adhesion disorders, fetal death, or growth restriction.

HIGHLIGHTS.

  • Invasion by extravillous trophoblasts and tumors is regulated by miRNA.

  • A C19MC miRNA, miR-519d, regulates cell migration, invasion, and extracellular matrix proteins.

  • MiR-519d is likely relevant to diseases associated with abnormal placentation.

Acknowledgments

We thank Lori Rideout for assistance with manuscript preparation and Bruce Campbell for editing. The work summarized in this review was supported by NIH R01HD065893 and R21HD071707 (both to YS).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Goldman-Wohl D, Yagel S. Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol. 2002;187:233–238. doi: 10.1016/s0303-7207(01)00687-6. [DOI] [PubMed] [Google Scholar]
  • 2.Cartwright JE, Fraser R, Leslie K, et al. Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders. Reproduction. 2010;140:803–813. doi: 10.1530/REP-10-0294. [DOI] [PubMed] [Google Scholar]
  • 3.Staun-Ram E, Shalev E. Human trophoblast function during the implantation process. Reprod Biol Endocrinol. 2005;3:56. doi: 10.1186/1477-7827-3-56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hemberger M. Immune balance at the foeto-maternal interface as the fulcrum of reproductive success. J Reprod Immunol. 2013;97:36–42. doi: 10.1016/j.jri.2012.10.006. [DOI] [PubMed] [Google Scholar]
  • 5.Ji L, Brkic J, Liu M, et al. Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. Mol Aspects Med. 2013;34:981–1023. doi: 10.1016/j.mam.2012.12.008. [DOI] [PubMed] [Google Scholar]
  • 6.Maltepe E, Bakardjiev AI, Fisher SJ. The placenta: transcriptional, epigenetic, and physiological integration during development. J Clin Invest. 2010;120:1016–1025. doi: 10.1172/JCI41211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Red-Horse K, Zhou Y, Genbacev O, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004;114:744–754. doi: 10.1172/JCI22991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Morales Prieto DM, Markert UR. MicroRNAs in pregnancy. J Reprod Immunol. 2011;88:106–111. doi: 10.1016/j.jri.2011.01.004. [DOI] [PubMed] [Google Scholar]
  • 9.Bortolin-Cavaille ML, Dance M, Weber M, et al. C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res. 2009;37:3464–3473. doi: 10.1093/nar/gkp205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Noguer-Dance M, Abu-Amero S, Al-Khtib M, et al. The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet. 2010;19:3566–3582. doi: 10.1093/hmg/ddq272. [DOI] [PubMed] [Google Scholar]
  • 11.Vaira V, Elli F, Forno I, et al. The microRNA cluster C19MC is deregulated in parathyroid tumours. J Mol Endocrinol. 2012;49:115–124. doi: 10.1530/JME-11-0189. [DOI] [PubMed] [Google Scholar]
  • 12.Rippe V, Dittberner L, Lorenz VN, et al. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS One. 2010;5:e9485. doi: 10.1371/journal.pone.0009485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Flor I, Bullerdiek J. The dark side of a success story: microRNAs of the C19MC cluster in human tumours. J Pathol. 2012;227:270–274. doi: 10.1002/path.4014. [DOI] [PubMed] [Google Scholar]
  • 14.Augello C, Vaira V, Caruso L, et al. MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int. 2012;32:772–782. doi: 10.1111/j.1478-3231.2012.02795.x. [DOI] [PubMed] [Google Scholar]
  • 15.Donker RB, Mouillet JF, Chu T, et al. The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod. 2012;18:417–424. doi: 10.1093/molehr/gas013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mouillet JF, Chu T, Hubel CA, et al. The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta. 2010;31:781–784. doi: 10.1016/j.placenta.2010.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Delorme-Axford E, Donker RB, Mouillet JF, et al. Human placental trophoblasts confer viral resistance to recipient cells. Proc Natl Acad Sci USA. 2013;110:12048–12053. doi: 10.1073/pnas.1304718110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ouyang Y, Mouillet JF, Coyne CB, et al. Review: Placenta-specific microRNAs in exosomes - Good things come in nano-packages. Placenta. 2013 doi: 10.1016/j.placenta.2013.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Delorme-Axford E, Bayer A, Sadovsky Y, et al. Autophagy as a mechanism of antiviral defense at the maternal?fetal interface. Autophagy. 2013;9:2173–2174. doi: 10.4161/auto.26558. [DOI] [PubMed] [Google Scholar]
  • 20.Bayer A, Delorme-Axford E, Sleigher C, et al. Human trophoblasts confer resistance to viruses implicated in perinatal infection. Am J Obstet Gynecol. 2015;212:71 e71–78. doi: 10.1016/j.ajog.2014.07.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zhu XM, Han T, Sargent IL, et al. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 2009;200:661 e661–667. doi: 10.1016/j.ajog.2008.12.045. [DOI] [PubMed] [Google Scholar]
  • 22.Ishibashi O, Ohkuchi A, Ali MM, et al. Hydroxysteroid (17-beta) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension. 2012;59:265–273. doi: 10.1161/HYPERTENSIONAHA.111.180232. [DOI] [PubMed] [Google Scholar]
  • 23.Hromadnikova I, Kotlabova K, Ondrackova M, et al. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications. DNA Cell Biol. 2015;34:437–457. doi: 10.1089/dna.2014.2687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yang Q, Lu J, Wang S, et al. Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women. Clin Chim Acta. 2011;412:2167–2173. doi: 10.1016/j.cca.2011.07.029. [DOI] [PubMed] [Google Scholar]
  • 25.Miura K, Higashijima A, Murakami Y, et al. Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia. J Obstet Gynaecol Res. 2015;41:1526–1532. doi: 10.1111/jog.12749. [DOI] [PubMed] [Google Scholar]
  • 26.Hromadnikova I, Kotlabova K, Hympanova L, et al. First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension. PLoS One. 2014;9:e113735. doi: 10.1371/journal.pone.0113735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hromadnikova I, Kotlabova K, Ondrackova M, et al. Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediators Inflamm. 2013;2013:186041. doi: 10.1155/2013/186041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Xie L, Mouillet JF, Chu T, et al. C19MC microRNAs regulate the migration of human trophoblasts. Endocrinology. 2014;155:4975–4985. doi: 10.1210/en.2014-1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Morales-Prieto DM, Chaiwangyen W, Ospina-Prieto S, et al. MicroRNA expression profiles of trophoblastic cells. Placenta. 2012;33:725–734. doi: 10.1016/j.placenta.2012.05.009. [DOI] [PubMed] [Google Scholar]
  • 30.Ding J, Huang F, Wu G, et al. MiR-519d-3p suppresses invasion and migration of trophoblast cells via targeting MMP-2. PLoS One. 2015;10:e0120321. doi: 10.1371/journal.pone.0120321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Fornari F, Milazzo M, Chieco P, et al. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol. 2012;227:275–285. doi: 10.1002/path.3995. [DOI] [PubMed] [Google Scholar]
  • 32.Fornari F, Ferracin M, Trere D, et al. Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC. PLoS One. 2015;10:e0141448. doi: 10.1371/journal.pone.0141448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhou JY, Zheng SR, Liu J, et al. MiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7. Cancer Cell Int. 2016;16:21. doi: 10.1186/s12935-016-0298-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Berenstein R, Blau O, Nogai A, et al. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region. BMC Cancer. 2015;15:68. doi: 10.1186/s12885-015-1078-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hou YY, Cao WW, Li L, et al. MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett. 2011;307:182–190. doi: 10.1016/j.canlet.2011.04.002. [DOI] [PubMed] [Google Scholar]
  • 36.Gennarino VA, D’Angelo G, Dharmalingam G, et al. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res. 2012;22:1163–1172. doi: 10.1101/gr.130435.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tsai HC, Su HL, Huang CY, et al. CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget. 2014;5:3800–3812. doi: 10.18632/oncotarget.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Pang Y, Mao H, Shen L, et al. MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP. Onco Targets Ther. 2014;7:587–597. doi: 10.2147/OTT.S60289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Deng X, Zhao Y, Wang B. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression. Oncol Rep. 2015;34:2188–2194. doi: 10.3892/or.2015.4160. [DOI] [PubMed] [Google Scholar]
  • 40.Tsai CH, Tsai HC, Huang HN, et al. Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells. Oncotarget. 2015;6:258–270. doi: 10.18632/oncotarget.2724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Martinelli R, Nardelli C, Pilone V, et al. miR-519d overexpression is associated with human obesity. Obesity (Silver Spring) 2010;18:2170–2176. doi: 10.1038/oby.2009.474. [DOI] [PubMed] [Google Scholar]
  • 42.Lu TM, Lu W, Zhao LJ. MicroRNA-137 affects proliferation and migration of placenta trophoblast cells in preeclampsia by targeting ERRalpha. Reprod Sci. 2016 doi: 10.1177/1933719116650754. [DOI] [PubMed] [Google Scholar]
  • 43.Yang M, Chen Y, Chen L, et al. miR-15b-AGO2 play a critical role in HTR8/SVneo invasion and in a model of angiogenesis defects related to inflammation. Placenta. 2016;41:62–73. doi: 10.1016/j.placenta.2016.03.007. [DOI] [PubMed] [Google Scholar]
  • 44.Ospina-Prieto S, Chaiwangyen W, Herrmann J, et al. MicroRNA-141 is upregulated in preeclamptic placentae and regulates trophoblast invasion and intercellular communication. Transl Res. 2016;172:61–72. doi: 10.1016/j.trsl.2016.02.012. [DOI] [PubMed] [Google Scholar]
  • 45.Zhou X, Li Q, Xu J, et al. The aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-beta signaling. Sci Rep. 2016;6:19910. doi: 10.1038/srep19910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Cuman C, Van Sinderen M, Gantier MP, et al. Human blastocyst secreted microRNA regulate endometrial epithelial cell adhesion. EBioMedicine. 2015;2:1528–1535. doi: 10.1016/j.ebiom.2015.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sun M, Chen H, Liu J, et al. MicroRNA-34a inhibits human trophoblast cell invasion by targeting MYC. BMC Cell Biol. 2015;16:21. doi: 10.1186/s12860-015-0068-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Umemura K, Ishioka S, Endo T, et al. Roles of microRNA-34a in the pathogenesis of placenta accreta. J Obstet Gynaecol Res. 2013;39:67–74. doi: 10.1111/j.1447-0756.2012.01898.x. [DOI] [PubMed] [Google Scholar]
  • 49.Pang RT, Leung CO, Ye TM, et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis. 2010;31:1037–1044. doi: 10.1093/carcin/bgq066. [DOI] [PubMed] [Google Scholar]
  • 50.Yu Y, Wang L, Liu T, et al. MicroRNA-204 suppresses trophoblast-like cell invasion by targeting matrix metalloproteinase-9. Biochem Biophys Res Commun. 2015;463:285–291. doi: 10.1016/j.bbrc.2015.05.052. [DOI] [PubMed] [Google Scholar]
  • 51.Zhu X, Yang Y, Han T, et al. Suppression of microRNA-18a expression inhibits invasion and promotes apoptosis of human trophoblast cells by targeting the estrogen receptor alpha gene. Mol Med Rep. 2015;12:2701–2706. doi: 10.3892/mmr.2015.3724. [DOI] [PubMed] [Google Scholar]
  • 52.Tamaru S, Mizuno Y, Tochigi H, et al. MicroRNA-135b suppresses extravillous trophoblast-derived HTR-8/SVneo cell invasion by directly down regulating CXCL12 under low oxygen conditions. Biochem Biophys Res Commun. 2015;461:421–426. doi: 10.1016/j.bbrc.2015.04.055. [DOI] [PubMed] [Google Scholar]
  • 53.Li Q, Pan Z, Wang X, et al. miR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia. Biochem Biophys Res Commun. 2014;453:57–63. doi: 10.1016/j.bbrc.2014.09.059. [DOI] [PubMed] [Google Scholar]
  • 54.Wang Y, Zhang Y, Wang H, et al. Aberrantly up-regulated miR-20a in pre-eclampsic placenta compromised the proliferative and invasive behaviors of trophoblast cells by targeting forkhead box protein A1. Int J Biol Sci. 2014;10:973–982. doi: 10.7150/ijbs.9088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Li X, Li C, Dong X, et al. MicroRNA-155 inhibits migration of trophoblast cells and contributes to the pathogenesis of severe preeclampsia by regulating endothelial nitric oxide synthase. Mol Med Rep. 2014;10:550–554. doi: 10.3892/mmr.2014.2214. [DOI] [PubMed] [Google Scholar]
  • 56.Dai Y, Qiu Z, Diao Z, et al. MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1. Placenta. 2012;33:824–829. doi: 10.1016/j.placenta.2012.07.012. [DOI] [PubMed] [Google Scholar]
  • 57.Zou Y, Jiang Z, Yu X, et al. MiR-101 regulates apoptosis of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum (ER) protein 44 during preeclampsia. J Hum Hypertens. 2014;28:610–616. doi: 10.1038/jhh.2014.35. [DOI] [PubMed] [Google Scholar]
  • 58.Fu G, Ye G, Nadeem L, et al. MicroRNA-376c impairs transforming growth factor-beta and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension. 2013;61:864–872. doi: 10.1161/HYPERTENSIONAHA.111.203489. [DOI] [PubMed] [Google Scholar]
  • 59.Bai Y, Yang W, Yang HX, et al. Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS One. 2012;7:e38875. doi: 10.1371/journal.pone.0038875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Li P, Guo W, Du L, et al. microRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. Clin Sci (Lond) 2013;124:27–40. doi: 10.1042/CS20120121. [DOI] [PubMed] [Google Scholar]
  • 61.Luo L, Ye G, Nadeem L, et al. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci. 2012;125:3124–3132. doi: 10.1242/jcs.096412. [DOI] [PubMed] [Google Scholar]

RESOURCES